Literature DB >> 2773312

Studies on Tanapox virus.

J C Knight1, F J Novembre, D R Brown, C S Goldsmith, J J Esposito.   

Abstract

Virus characterization studies were performed to meliorate the taxonomic status of three currently unclassified, serologically related viruses: Tanapox virus (causes vesicular skin lesions in humans), Yaba-like disease (YLD) virus (causes vesicular skin lesions in monkeys), and Yaba monkey tumor virus (YMTV, causes epidermal histiocytoma). These studies included (1) microscopic observations of Tanapox virus cytopathic effect and morphogenesis during its 6-day cytolytic-type growth at 35 degrees in CV-1 monkey kidney cells; (2) resolution of Tanapox virion proteins by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of nonenveloped and double-enveloped virus particles purified by velocity sedimentation in sucrose and CsCl density gradients; and (3) restriction endonuclease DNA comparison of the three viruses. DNA analysis showed that six recent Tanapox virus isolates from patients in Zaire, Africa, were identical to Tanapox virus, Kenya strain, from 1957 from a patient in the Tana River Valley. In addition, BamHI, MluI, and PstI cleavage sites mapped on the DNA of Kenya Tanapox virus, and PstI sites mapped on DNA of YLD virus differentiated YLD and Tanapox viruses as separate strains. On the other hand, YMTV shared few restriction endonuclease sites with Tanapox and YLD viruses, although all three cross-hybridized extensively. These studies along with published viral characteristics, support the formation of a new poxvirus genus: the suggested name is Yatapoxvirus, and the genus currently comprises two species, Tanapox virus and YMTV.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2773312     DOI: 10.1016/0042-6822(89)90113-x

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  A poxvirus protein forms a complex with left-handed Z-DNA: crystal structure of a Yatapoxvirus Zalpha bound to DNA.

Authors:  Sung Chul Ha; Neratur K Lokanath; Dong Van Quyen; Chun Ai Wu; Ky Lowenhaupt; Alexander Rich; Yang-Gyun Kim; Kyeong Kyu Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-24       Impact factor: 11.205

2.  Yaba-like disease virus: an alternative replicating poxvirus vector for cancer gene therapy.

Authors:  Y Hu; J Lee; J A McCart; H Xu; B Moss; H R Alexander; D L Bartlett
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 3.  Replicating poxviruses for human cancer therapy.

Authors:  Manbok Kim
Journal:  J Microbiol       Date:  2015-04-08       Impact factor: 2.902

4.  Yaba monkey tumor virus encodes a functional inhibitor of interleukin-18.

Authors:  Steven H Nazarian; Masmudur M Rahman; Steven J Werden; Danielle Villeneuve; Xiangzhi Meng; Craig Brunetti; Chalice Valeriano; Christina Wong; Rajkumari Singh; John W Barrett; Yan Xiang; Grant McFadden
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

5.  Differential susceptibility of human cancer cell lines to wild-type tanapoxvirus infection.

Authors:  Hui Lin Lee; Karim Essani
Journal:  Open Virol J       Date:  2010-04-08

6.  PCR strategy for identification and differentiation of small pox and other orthopoxviruses.

Authors:  S L Ropp; Q Jin; J C Knight; R F Massung; J J Esposito
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

Review 7.  Poxviruses and the evolution of host range and virulence.

Authors:  Sherry L Haller; Chen Peng; Grant McFadden; Stefan Rothenburg
Journal:  Infect Genet Evol       Date:  2013-10-24       Impact factor: 3.342

8.  Complete genomic sequence and comparative analysis of the tumorigenic poxvirus Yaba monkey tumor virus.

Authors:  Craig R Brunetti; Hiroko Amano; Yoshiaki Ueda; Jing Qin; Tatsuo Miyamura; Tetsuro Suzuki; Xing Li; John W Barrett; Grant McFadden
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

Review 9.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

10.  A unique bivalent binding and inhibition mechanism by the yatapoxvirus interleukin 18 binding protein.

Authors:  Brian Krumm; Xiangzhi Meng; Zhixin Wang; Yan Xiang; Junpeng Deng
Journal:  PLoS Pathog       Date:  2012-08-23       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.